|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Howlader N, Noone AM, Yu M and Cronin KA:
Use of imputed population-based cancer registry data as a method of
accounting for missing information: Application to estrogen
receptor status for breast cancer. Am J Epidemiol. 176:347–356.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoffman PC, Mauer AM and Vokes EE: Lung
cancer. Lancet. 355:479–485. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vicent S, Luis-Ravelo D, Antón I,
García-Tuñón I, Borrás-Cuesta F, Dotor J, De Las, Rivas J and
Lecanda F: A novel lung cancer signature mediates metastatic bone
colonization by a dual mechanism. Cancer Res. 68:2275–2285. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahn Y, Sims C, Murray MJ, Kuhlmann PK,
Fuentes-Antrás J, Weatherbee SD and Krumlauf R: Multiple modes of
Lrp4 function in modulation of Wnt/β-catenin signaling during tooth
development. Development. 144:2824–2836. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Närhi K, Tummers M, Ahtiainen L, Itoh N,
Thesleff I and Mikkola ML: Sostdc1 defines the size and number of
skin appendage placodes. Dev Biol. 364:149–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collette NM, Yee CS, Murugesh D, Sebastian
A, Taher L, Gale NW, Economides AN, Harland RM and Loots GG: Sost
and its paralog Sostdc1 coordinate digit number in a Gli3-dependent
manner. Dev Biol. 383:90–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shigetani Y, Howard S, Guidato S,
Furushima K, Abe T and Itasaki N: Wise promotes coalescence of
cells of neural crest and placode origins in the trigeminal region
during head development. Dev Biol. 319:346–358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang W, Guan H, He X, Ke W, Xu L, Liu L,
Xiao H and Li Y: Down-regulation of SOSTDC1 promotes thyroid cancer
cell proliferation via regulating cyclin A2 and cyclin E2.
Oncotarget. 6:31780–31791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rawat A, Gopisetty G and Thangarajan R:
E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression
in breast cancer cells. Cell Oncol. 37:409–419. 2014. View Article : Google Scholar
|
|
12
|
Gopal G, Raja UM, Shirley S, Rajalekshmi
KR and Rajkumar T: SOSTDC1 down-regulation of expression involves
CpG methylation and is a potential prognostic marker in gastric
cancer. Cancer Genet. 206:174–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blish KR, Wang W, Willingham MC, Du W,
Birse CE, Krishnan SR, Brown JC, Hawkins GA, Garvin AJ, D’Agostino
RB Jr, et al: A human bone morphogenetic protein antagonist is
down-regulated in renal cancer. Mol Biol Cell. 19:457–464. 2008.
View Article : Google Scholar :
|
|
14
|
Zhou Q, Chen J, Feng J, Xu Y, Zheng W and
Wang J: SOSTDC1 inhibits follicular thyroid cancer cell
proliferation, migration, and EMT via suppressing PI3K/Akt and
MAPK/Erk signaling pathways. Mol Cell Biochem. 435:87–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Henley KD, Gooding KA, Economides AN and
Gannon M: Inactivation of the dual Bmp/Wnt inhibitor Sostdc1
enhances pancreatic islet function. Am J Physiol Endocrinol Metab.
303:E752–E761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Itasaki N, Jones CM, Mercurio S, Rowe A,
Domingos PM, Smith JC and Krumlauf R: Wise, a context-dependent
activator and inhibitor of Wnt signalling. Development.
130:4295–4305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu L, Wu S, Yang Y, Cai J, Zhu X, Wu J,
Li M and Guan H: SOSTDC1 is down-regulated in non-small cell lung
cancer and contributes to cancer cell proliferation. Cell Biosci.
6:242016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koul R, Rathod S, Dubey A, Bashir B and
Chowdhury A: Comparison of 7th and 8th editions of the UICC/AJCC
TNM staging for nonsmall cell lung cancer in a non-metastatic North
American cohort undergoing primary radiation treatment. Lung
Cancer. 123:116–120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Driver BR, Barrios R, Ge Y, Haque A, Tacha
D and Cagle PT: Folate receptor α expression level correlates with
histologic grade in lung adenocarcinoma. Arch Pathol Lab Med.
140:682–685. 2016. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔC T method. Methods. 25:402–408.
2001. View Article : Google Scholar
|
|
21
|
Wang T, Yin H, Wang J, Li Z, Wei H, Liu Z,
Wu Z, Yan W, Liu T, Song D, et al: MicroRNA-106b inhibits
osteoclastogenesis and osteolysis by targeting RANKL in giant cell
tumor of bone. Oncotarget. 6:18980–18996. 2015.PubMed/NCBI
|
|
22
|
Zhou W, Yin H, Wang T, Liu T, Li Z, Yan W,
Song D, Chen H, Chen J, Xu W, et al: MiR-126-5p regulates
osteolysis formation and stromal cell proliferation in giant cell
tumor through inhibition of PTHrP. Bone. 66:267–276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Laurikkala J, Kassai Y, Pakkasjärvi L,
Thesleff I and Itoh N: Identification of a secreted BMP antagonist,
ectodin, integrating BMP, FGF, and SHH signals from the tooth
enamel knot. Dev Biol. 264:91–105. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kamiya N: The role of BMPs in bone
anabolism and their potential targets SOST and DKK1. Curr Mol
Pharmacol. 5:153–163. 2012. View Article : Google Scholar
|
|
25
|
Okamoto M, Murai J, Yoshikawa H and
Tsumaki N: Bone morphogenetic proteins in bone stimulate
osteoclasts and osteoblasts during bone development. J Bone Miner
Res. 21:1022–1033. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Collette NM, Yee CS, Hum NR, Murugesh DK,
Christiansen BA, Xie L, Economides AN, Manilay JO, Robling AG and
Loots GG: Sostdc1 deficiency accelerates fracture healing by
promoting the expansion of periosteal mesenchymal stem cells. Bone.
88:20–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Togo Y, Takahashi K, Saito K, Kiso H,
Tsukamoto H, Huang B, Yanagita M, Sugai M, Harada H, Komori T, et
al: Antagonistic functions of USAG-1 and RUNX2 during tooth
development. PLoS One. 11:e01610672016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujita K, Roforth MM, Demaray S, McGregor
U, Kirmani S, McCready LK, Peterson JM, Drake MT, Monroe DG and
Khosla S: Effects of estrogen on bone mRNA levels of sclerostin and
other genes relevant to bone metabolism in postmenopausal women. J
Clin Endocrinol Metab. 99:E81–E88. 2014. View Article : Google Scholar :
|
|
29
|
Prochazkova M, Häkkinen TJ, Prochazka J,
Spoutil F, Jheon AH, Ahn Y, Krumlauf R, Jernvall J and Klein OD:
FGF signaling refines Wnt gradients to regulate the patterning of
taste papillae. Development. 144:2212–2221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JW, Wang P, Kattah MG, Youssef S,
Steinman L, DeFea K and Straus DS: Differential regulation of
chemokines by IL-17 in colonic epithelial cells. J Immunol.
181:6536–6545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S
and Watanabe S: Visfatin enhances CXCL8, CXCL10, and CCL20
production in human keratinocytes. Endocrinology. 152:3155–3164.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hardaway AL, Herroon MK, Rajagurubandara E
and Podgorski I: Marrow adipocyte-derived CXCL1 and CXCL2
contribute to osteolysis in metastatic prostate cancer. Clin Exp
Metastasis. 32:353–368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu P, Lee S, Knoll J, Rauch A, Ostermay
S, Luther J, Malkusch N, Lerner UH, Zaiss MM, Neven M, et al: Loss
of menin in osteoblast lineage affects osteocyte-osteoclast
crosstalk causing osteoporosis. Cell Death Differ. 24:672–682.
2017. View Article : Google Scholar : PubMed/NCBI
|
